Phuong N. Huynh

Array ( [id] => 6538498 [patent_doc_number] => 20100221751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'METHOD OF SCREENING ENDOTHELIAL CELLS FOR ANGIOGENIC CAPABILITY' [patent_app_type] => utility [patent_app_number] => 12/463010 [patent_app_country] => US [patent_app_date] => 2009-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3140 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221751.pdf [firstpage_image] =>[orig_patent_app_number] => 12463010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495446 [patent_doc_number] => 20090263474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays' [patent_app_type] => utility [patent_app_number] => 12/435267 [patent_app_country] => US [patent_app_date] => 2009-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16648 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263474.pdf [firstpage_image] =>[orig_patent_app_number] => 12435267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616604 [patent_doc_number] => 20100003253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/431403 [patent_app_country] => US [patent_app_date] => 2009-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 54403 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003253.pdf [firstpage_image] =>[orig_patent_app_number] => 12431403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11888043 [patent_doc_number] => 09758594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Stable multivalent antibody' [patent_app_type] => utility [patent_app_number] => 12/989600 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28066 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12989600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160676 [patent_doc_number] => 20120101261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'USE OF MULTI-KINASE INHIBITORS IN THE TREATMENT OF VASCULAR HYPERPERMEABILITY' [patent_app_type] => utility [patent_app_number] => 13/263402 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2771 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101261.pdf [firstpage_image] =>[orig_patent_app_number] => 13263402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484945 [patent_doc_number] => 20090274710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 12/421398 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12298 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274710.pdf [firstpage_image] =>[orig_patent_app_number] => 12421398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490027 [patent_doc_number] => 20090291098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Immunogenic LHRH compositions and methods relating thereto' [patent_app_type] => utility [patent_app_number] => 12/384974 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7169 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291098.pdf [firstpage_image] =>[orig_patent_app_number] => 12384974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5403443 [patent_doc_number] => 20090238757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Methods and Compositions for Administering Therapeutic and Diagnostic Agents' [patent_app_type] => utility [patent_app_number] => 12/420864 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 34554 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20090238757.pdf [firstpage_image] =>[orig_patent_app_number] => 12420864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479530 [patent_doc_number] => 20090202487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Modular Method to Prepare Tetrameric Cytokines with Improved Pharmacokinetics by the Dock-and-Lock (DNL) Technology' [patent_app_type] => utility [patent_app_number] => 12/418877 [patent_app_country] => US [patent_app_date] => 2009-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22869 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202487.pdf [firstpage_image] =>[orig_patent_app_number] => 12418877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479476 [patent_doc_number] => 20090202433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses' [patent_app_type] => utility [patent_app_number] => 12/417917 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19218 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202433.pdf [firstpage_image] =>[orig_patent_app_number] => 12417917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968148 [patent_doc_number] => 08506958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Methods for treating TWEAK-related conditions' [patent_app_type] => utility [patent_app_number] => 12/417755 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 19010 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12417755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397295 [patent_doc_number] => 20090317358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'CHIMERIC PROTEINS WITH CELL-TARGETING SPECIFICITY AND APOPTOSIS-INDUCING ACTIVITIES' [patent_app_type] => utility [patent_app_number] => 12/417277 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11663 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317358.pdf [firstpage_image] =>[orig_patent_app_number] => 12417277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385239 [patent_doc_number] => 20090226484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Immunogenic LHRH compositions and methods relating thereto' [patent_app_type] => utility [patent_app_number] => 12/384242 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7169 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226484.pdf [firstpage_image] =>[orig_patent_app_number] => 12384242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6201939 [patent_doc_number] => 20110064725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'HIGH AFFINITY, ANTI-HUMAN IGE ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/413014 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18360 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064725.pdf [firstpage_image] =>[orig_patent_app_number] => 12413014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552748 [patent_doc_number] => 20090286734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Pharmaceutical Use of Alpha Antigen or Alpha Antigen Gene' [patent_app_type] => utility [patent_app_number] => 12/405844 [patent_app_country] => US [patent_app_date] => 2009-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5442 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286734.pdf [firstpage_image] =>[orig_patent_app_number] => 12405844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4458888 [patent_doc_number] => 07879324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Fusion molecules and methods for treatment of immune diseases' [patent_app_type] => utility [patent_app_number] => 12/404012 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33575 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879324.pdf [firstpage_image] =>[orig_patent_app_number] => 12404012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551845 [patent_doc_number] => 20090285831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'IMMUNOINTERACTIVE MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/403897 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11454 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285831.pdf [firstpage_image] =>[orig_patent_app_number] => 12403897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096219 [patent_doc_number] => 20110003338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'ANTIBODIES WITH ENHANCED ADCC FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/922111 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13836 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003338.pdf [firstpage_image] =>[orig_patent_app_number] => 12922111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379359 [patent_doc_number] => 20090191198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'METHODS FOR BLOCKING THE INTERACTION BETWEEN NKP80 AND ITS LIGANDS' [patent_app_type] => utility [patent_app_number] => 12/397188 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8928 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191198.pdf [firstpage_image] =>[orig_patent_app_number] => 12397188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4564377 [patent_doc_number] => 07858070 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Multivalent immunoglobulin-based bioactive assemblies' [patent_app_type] => utility [patent_app_number] => 12/396605 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 50556 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858070.pdf [firstpage_image] =>[orig_patent_app_number] => 12396605 [rel_patent_id] =>[rel_patent_doc_number] =>)